Treatment of Congenital Stationary Night Blindness With an Alga Containing High Dose of Beta Carotene

Night Blindness Clinical Trial

Official title: Treatment of Congenital Stationary Night Blindness With an Alga Containing High Dose of Beta Carotene

Status Completed

Clinical Trial Summary

To assess the effect of oral administration of the alga Dunaliella bardawil containing approximately 50% all-trans beta-carotene and 50% 9-cis beta-carotene isomers on visual functions patients with Congenital Stationary Night Blindness {Fundus albipunctatus).

Clinical Trial Description

n/a

Study Design

Endpoint Classification: Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Treatment

Related Conditions & MeSH terms

• Blindness
• Eye Diseases, Hereditary
• Genetic Diseases, X-Linked
• Myopia
• Night Blindness
• Vitamin A Deficiency

• NCT number: NCT00569023
• Study type: Interventional
• Source: Sheba Medical Center
• Status: Completed
• Phase: N/A
• Start date: July 2007
• Completion date: July 2010